ETHZilla, formerly known as 180 Life Sciences Corp., has completed its rebranding and aims to provide exposure to Ethereum through public markets, holding approximately 94,675 ETH valued at around $419 million. Backed by notable investors including Peter Thiel’s Founders Fund, the firm is focusing on a differentiated on-chain yield generation program to enhance returns beyond traditional ETH staking.